{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:21:01Z","timestamp":1780435261075,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T00:00:00Z","timestamp":1294358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00436-010-2230-2","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T03:42:36Z","timestamp":1294285356000},"page":"793-800","source":"Crossref","is-referenced-by-count":23,"title":["Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator\u2014picroliv"],"prefix":"10.1007","volume":"108","author":[{"given":"Nishi","family":"Shakya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha A.","family":"Sane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,7]]},"reference":[{"key":"2230_CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","volume":"346","author":"AA Alrajhi","year":"2002","unstructured":"Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH (2002) A six-week course of oral fluconazole, in a dose of 200\u00a0mg daily for 6\u00a0weeks, is a safe and useful treatment for cutaneous leishmaniasis caused by L. major. N Engl J Med 346:891\u2013895","journal-title":"N Engl J Med"},{"key":"2230_CR2","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","volume":"33","author":"I Arevalo","year":"2001","unstructured":"Arevalo I, Ward B, Miller R (2001) Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 33:1847\u20131851","journal-title":"Clin Infect Dis"},{"key":"2230_CR3","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1128\/AAC.49.9.3776-3783.2005","volume":"49","author":"GS Ashutosh","year":"2005","unstructured":"Ashutosh GS, Ramesh SS, Goyal N (2005) Use of L. donovani field isolates expressing luciferase reporter gene in in vitro drug screening. Antimicrob Agents Chemother 49:3776\u20133783","journal-title":"Antimicrob Agents Chemother"},{"key":"2230_CR4","first-page":"439","volume":"89","author":"S Bhatnagar","year":"1989","unstructured":"Bhatnagar S, Guru PY, Katiyar JC, Srivastava R, Mukherjee A, Akhtar MS, Seth M, Bhaduri AP (1989) Exploration of antileishmanial activity in heterocycles; results of their in vivo and in vitro bioevaluations. Indian J Med Res 89:439\u2013444","journal-title":"Indian J Med Res"},{"key":"2230_CR5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","volume":"179","author":"S Buates","year":"1999","unstructured":"Buates S, Matlashewski G (1999) Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 179:1485\u20131494","journal-title":"J Infect Dis"},{"key":"2230_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/00365540500321405","volume":"38","author":"M Colakoglu","year":"2006","unstructured":"Colakoglu M, Yaylali G, Colakoglu NY, Yalmaz M (2006) Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure. Scand J Infect Dis 38:208\u2013210","journal-title":"Scand J Infect Dis"},{"key":"2230_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","volume":"8","author":"SL Croft","year":"2002","unstructured":"Croft SL, Yardley V (2002) Chemotherapy of leishmaniasis. Curr Pharmaceutic Des 8:319\u2013342","journal-title":"Curr Pharmaceutic Des"},{"key":"2230_CR8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/eri.10.64","volume":"8","author":"JE Dalton","year":"2010","unstructured":"Dalton JE, Kaye PM (2010) Immunomodulators: use in combined therapy against leishmaniasis. Expert Rev Anti Infect Ther 8:739\u2013742","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2230_CR9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0773.1992.tb00566.x","volume":"71","author":"Y Dwivedi","year":"1992","unstructured":"Dwivedi Y, Rastogi R, Garg NK, Dhawan BN (1992) Picroliv and its components kutkoside and picroside I protect liver against galactosamine induced damage in rats. Pharmacol Toxicol 71:383\u2013387","journal-title":"Pharmacol Toxicol"},{"key":"2230_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","volume":"10","author":"J Griensven","year":"2010","unstructured":"Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10:184\u201394","journal-title":"Lancet Infect Dis"},{"key":"2230_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actatropica.2004.11.009","volume":"94","author":"S Gupta","year":"2005","unstructured":"Gupta S, Ramesh SSC, Shrivastava VML (2005) Efficacy of picroliv combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis. Acta Trop 94:41\u201347","journal-title":"Acta Trop"},{"key":"2230_CR12","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.bmcl.2007.04.035","volume":"17","author":"L Gupta","year":"2007","unstructured":"Gupta L, Talwar A, Nishi PS, Gupta S, Chauhan PMS (2007) Synthesis of marine alkaloid 8,9 dihydrocoscinamide B and its analogues as a novel class of antileishmanial agents. Bioorg Med Chem Lett 17:4075\u20134079","journal-title":"Bioorg Med Chem Lett"},{"key":"2230_CR13","first-page":"268","volume":"35","author":"BB Jha","year":"1998","unstructured":"Jha BB (1998) Fluconazole in visceral leishmaniasis. Indian Pediatr 35:268\u2013269","journal-title":"Indian Pediatr"},{"key":"2230_CR14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","volume":"157","author":"HW Murray","year":"1988","unstructured":"Murray HW, Berman JD, Wright SD (1988) Immunotherapy for intracellular L. donovani infection: gamma interferon plus pentavalent antimony. J Infect Dis 157:973\u2013978","journal-title":"J Infect Dis"},{"key":"2230_CR15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00436-006-0394-6","volume":"100","author":"SV Mussi","year":"2007","unstructured":"Mussi SV, Fernandes AP, Ferreira LAM (2007) Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis. Parasitol Res 100:1221\u20131226","journal-title":"Parasitol Res"},{"key":"2230_CR16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-2006-961542","volume":"58","author":"A Puri","year":"1992","unstructured":"Puri A, Saxena RP, Guru PY, Kulshreshtha DK, Saxena KC, Dhawan BN (1992) Immunostimulant activity of Picroliv, the iridoid glycoside fraction of P. kurroa and its protective action against L. donovani infection in hamsters. Planta Med 58:528\u2013532","journal-title":"Planta Med"},{"key":"2230_CR17","first-page":"459","volume":"19","author":"NV Rajeshkumar","year":"2000","unstructured":"Rajeshkumar NV, Kuttan R (2000) Inhibition of N-nitrosodiethylamine-induced hepatocarcinogenesis by picroliv. J Exp Clin Cancer Res 19:459\u2013465","journal-title":"J Exp Clin Cancer Res"},{"key":"2230_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF02867970","volume":"17","author":"A Ray","year":"2002","unstructured":"Ray A, Chaudhuri SR, Majumdar B, Bandyopadhyay SK (2002) Antioxidant activity of ethanol extract of rhizome of P. kurroa on indomethacin-induced gastric ulcer during healing. Ind J Clin Biochem 17:44\u201351","journal-title":"Ind J Clin Biochem"},{"key":"2230_CR19","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jac\/dkq164","volume":"65","author":"SA Sane","year":"2010","unstructured":"Sane SA, Shakya N, Haq W, Gupta S (2010) CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis. J Antimicro Chemother 65:1448\u20131454","journal-title":"J Antimicro Chemother"},{"key":"2230_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","volume":"50","author":"K Seifert","year":"2006","unstructured":"Seifert K, Croft SL (2006) In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob Agents Chemother 50:73\u201379","journal-title":"Antimicrob Agents Chemother"},{"key":"2230_CR21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1189\/jlb.0903415","volume":"75","author":"P Sharma","year":"2004","unstructured":"Sharma P, Raghavan SAV, Saini R, Dikshit M (2004) Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocyte: modulatory effect of nitric oxide. J Leukocyte Biol 75:1070\u20131078","journal-title":"J Leukocyte Biol"},{"key":"2230_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0031182003003457","volume":"127","author":"JK Shrivastava","year":"2003","unstructured":"Shrivastava JK, Misra A, Sharma P, Srivastava B, Naik S, Dube A (2003) Prophylactic potential of autoclaved L. donovani with BCG against experimental visceral leishmaniasis. Parasitol 127:107\u2013114","journal-title":"Parasitol"},{"issue":"324","key":"2230_CR23","first-page":"327","volume":"19","author":"N Srinivas","year":"2009","unstructured":"Srinivas N, Palne S, Nishi GS, Bhandari K (2009) Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents. Bioorg Med Chem 19(324):327","journal-title":"Bioorg Med Chem"},{"issue":"9027","key":"2230_CR24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(05)64828-3","volume":"348","author":"S Sundar","year":"1996","unstructured":"Sundar S, Singh VP, Agrawal NK, Gibbs DL, Murray HW (1996) Treatment of kala-azar with oral fluconazole. Lancet 348(9027):614","journal-title":"Lancet"},{"key":"2230_CR25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/37.5.1042","volume":"37","author":"D Torrus","year":"1996","unstructured":"Torrus D, Boix V, Massa B, Portilla J, Perez-Mateo M (1996) Fluconazole plus allopurinol in treatment of visceral leishmaniasis. J Antimicrob Chemother 37:1042\u20131043","journal-title":"J Antimicrob Chemother"},{"key":"2230_CR26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138920109789069314","volume":"10","author":"PC Verma","year":"2009","unstructured":"Verma PC, Vaishali B, Gupta V, Saxena G, Rahman LU (2009) Pharmacology and chemistry of a potent hepatoprotective compound picroliv isolated from the roots and rhizomes of Picrorhiza kurroa Royle ex Benth. (Kutki). Curr Pharmaceut Biotec 10:641\u2013649","journal-title":"Curr Pharmaceut Biotec"},{"key":"2230_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(03)00086-X","volume":"331","author":"S Walrand","year":"2003","unstructured":"Walrand S, Valeix S, Rodriguez C, Ligot P, Chassagne J, Vasson MP (2003) Flow cytometry study of polymorphonuclear neutrophiloxidative burst: a comparison of three fluorescent probes. Clin Chem Acta 331:103\u2013110","journal-title":"Clin Chem Acta"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-010-2230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-010-2230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-010-2230-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:56:21Z","timestamp":1559069781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-010-2230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["2230"],"URL":"https:\/\/doi.org\/10.1007\/s00436-010-2230-2","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,7]]}}}